SYSTEM ONLINE
SUPPORT
Menu

Quick Categories

AOD-9604
Peptides

AOD-9604

$60.00 - $120.00
Multiple options available
AOD-9604AOD-9604 (Anti-Obesity Drug-9604) is a synthetic peptide fragment of human growth hormone (HGH), consisting of amino acids 176–191. Unlike full HGH, AOD...

Select Formulation

2 specifications available

Lab Verified

product-code-spec: 5AD | 5mg10vials

$60.00

SKU: SKU-PYMTLXRH

product-code-spec: 10AD | 10mg10vials

$120.00

SKU: SKU-SKRZRIUW

Category

Product SKU SKU-MWHR934Q

AOD-9604

AOD-9604 (Anti-Obesity Drug-9604) is a synthetic peptide fragment of human growth hormone (HGH), consisting of amino acids 176–191. Unlike full HGH, AOD-9604 does not stimulate IGF-1 production or general growth pathways. Instead, it has been studied primarily for its potential role in regulating fat metabolism. It remains experimental and is not FDA-approved as a therapy.

How It Is Used in Research Settings

  • Explored for stimulating lipolysis (fat breakdown) and inhibiting lipogenesis (fat storage) in adipose tissue models.
  • Studied in obesity and metabolic syndrome research for weight management support.
  • Examined in animal studies for potential effects on cartilage repair and joint health.
  • Investigated as a safer alternative to HGH without impacting blood sugar or IGF-1 pathways.

Proposed Uses (Research Areas)

  • Obesity and fat metabolism studies.
  • Metabolic syndrome and insulin resistance models.
  • Joint repair and cartilage protection (preclinical data).
  • Aging and weight management research.

How It Is Dosed in Research Settings

  • Injectable: Typically studied at 300 mcg to 600 mcg subcutaneously once daily.
  • Oral formulations: Investigated in capsule form, though bioavailability and efficacy are less well established.
  • Cycle length: Common research protocols range from 12–24 weeks for weight and metabolic outcomes.
  • Handling: Supplied as a lyophilized powder; reconstituted with bacteriostatic water and stored refrigerated.

Important Considerations

  • Regulatory status: AOD-9604 is not FDA-approved; all applications remain experimental.
  • Evidence base: Most data comes from preclinical studies and small clinical trials; larger studies are needed.
  • Safety: Reported as well tolerated in short studies, with low risk of hypoglycemia compared to HGH. Long-term safety is unknown.

Disclaimer

This material is provided for educational purposes only and summarizes published research on AOD-9604. It is not medical advice. AOD-9604 is experimental, not FDA-approved, and should not be viewed as a therapy for medical use.

This peptide is for research use only.

Related Compounds

Batch: #75887
Sermorelin
Peptides

Sermorelin

Price

$128.00
View
Batch: #158f3
VIP Peptide 10mg
Peptides

VIP Peptide 10mg

Price

$39.99
View
Batch: #950a4
KPV 10mg
Peptides

KPV 10mg

Price

$55.00
View
Batch: #9dfcd
Oxytocin (10mg)
Peptides

Oxytocin (10mg)

Price

$45.00
View

BioSync Support

Online | Replies Instantly

Need assistance with your order or research compounds? Chat with our team directly.

+44 7745 352257
Start Chat